The life-changing effects of gene therapy for Leber congenital amaurosis

Published on May 7, 2026
Six years after Jake Ternent was the first patient to receive Luxturna on the NHS, he describes the impact of treatment on his daily life
Continue reading on website
Other news

Alcon Reports First Quarter Growth Boosted by New Product Launches

May 7, 2026
GENEVA—Alcon (SIX/NYSE:ALC), a global leader in eyecare, announced its financial results for the three months ending March 31, 2026. For the first quarter of 2026, sales were $2.7 billion, up 10 percent on a reported basis and up 6 percent on a constant currency basis, as compared with the same quarter of the previous year. Vision care net sales, which include contact lenses and ocular health, rea

Blind journalist unable to vote independently in local elections

May 7, 2026
The RNIB is highlighting the issue of inaccessible voting after journalist Selina Mills was forced to let her husband fill in her ballot paper in Pimlico yesterday